Parkinson's disease, adaptive deep brain stimulation and FDA

FDA approves first adaptive deep brain stimulation system for Parkinson’s disease
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the manufacturer.
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
New research uncovers brain changes in Parkinson's disease
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced imaging techniques.
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation ap | The company said its U.
FDA approves Medtronic device for Parkinson's treatment
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain activity,
Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology.
FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Studies of Parkinson's disease have long overlooked Pacific populations—meta-analysis shows why that must change
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
Jake Paul causes Mike Tyson Parkinson’s disease stir in wild interview after controversial fight
The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...
psychiatryadvisor.com1d
Sleep Problems in Parkinson Disease Are Prevalent and Impair Daily Function, QoL
Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.
LJI scientists discover a potential new target for treating Parkinson's disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
News Medical on MSN7d
Cholesterol metabolite linked to Parkinson's disease development in mice
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...
Mike Tyson Sets Record Straight On Parkinson’s Disease Rumors
Mike Tyson is setting the record straight amid rumors he has Parkinson's Disease following comments made by Jake Paul.   The ...
Hosted on MSN1d
FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
News Medical on MSN9h
Can coffee push back Parkinson’s? New study uncovers key genetic link
Higher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or ...